An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)

R. C. Coombes, T. Tat, M. L. Miller, J. A. Reise, J. L. Mansi, D. J. Hadjiminas, S. Shousha, S. E. Elsheikh, E. W-F. Lam, Y. Horimoto, M. El-Bahrawy, E. O. Aboagye, K. B. Contractor, J. A. Shaw, R. A. Walker, M. H. Marconell, C. Palmieri, J. Stebbing^*